Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies – MedCity News
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…
Alzheimer’s disease can be treated with antibodies that clear away plaques of amyloid protein, but these medicines require frequent dosing…
Models are out, molecules are in as AI startups sprint to clinic Endpoints News Source link
Home to leading hospitals, universities and health-focused incubators, Houston is a breeding ground for innovative medical technology and breakthroughs that…